Overall, the predictors we found can be categorized into three main groups: the surprise question; clinical variables (age, male sex, disease stage, performance status, comorbidity, cognitive impairment, (sub)cutaneous metastases, and lung cancer); and laboratory variables (serum albumin and hemoglobin). This evidence concerns the gene ALB and lung carcinoma.